Medical Technology Company Announces Launch of FDA-Registered External Male Catheter Device

Avalon GloboCare Corp. (NASDAQ: ALBT), a company known for its innovative cell-based technology, cellular therapy, and precision diagnostics, has recently made a significant announcement. Laboratory Services MSO, LLC (LSM), a company in which Avalon holds a 40% stake, has begun the manufacturing of the GeeWhiz External Condom Catheter. This FDA-registered and patented male incontinence device is expected to hit the market in the third quarter of 2024. $Avalon GloboCare (ALBT.US)$